Sanara MedTech (SMTI) Change in Accured Expenses (2010 - 2024)

Sanara MedTech (SMTI) has 14 years of Change in Accured Expenses data on file, last reported at -$783390.0 in Q1 2024.

• Quarterly Change in Accured Expenses rose 59.81% year-over-year to -$783390.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1.1 million (down 25.46% YoY) and the FY2023 annual result came in at -$81513.0, down 102.72% from the prior year.
• Change in Accured Expenses eased to -$783390.0 in Q1 2024, from $1.6 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q4 2023 to a low of -$1.9 million in Q1 2023.
• A 5-year average of $231970.4 and a median of $225008.0 in 2021 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2020 — Change in Accured Expenses plunged 380.24% — and 2021, when it surged 693.02%.
• Tracing SMTI's Change in Accured Expenses over 5 years: stood at $888265.0 in 2020, then tumbled by 48.39% to $458405.0 in 2021, then jumped by 222.35% to $1.5 million in 2022, then climbed by 7.75% to $1.6 million in 2023, then slumped by 149.2% to -$783390.0 in 2024.
• The last three Change in Accured Expenses figures came in at -$783390.0 (Q1 2024), $1.6 million (Q4 2023), and $185400.0 (Q3 2023), per Business Quant data.